The company anticipates full-year 2017 revenues to fall between $274 million and $285 million.
Q4 2016 results
1. RTI experienced a net loss of $12 million or $0.21 per fully diluted share.
2. The company’s worldwide revenues totaled $71.3 million, reflecting a 6 percent decrease from the same period the year prior.
3. RTI’s domestic revenues totaled $64.6 million, representing a 9 percent decrease from Q4 of 2015.
4. International revenues totaled $6.8 million, reflecting a 24 percent increase from the same period the year prior, due to spine growth in Asia.
5. Direct revenues increased 22 percent to $44.5 million.
6. The company’s spine business continues to grow, due to increases in surgeon users and distributor relationships.
Full-year 2016 results
7. Worldwide revenue increased to $272.9 million, down 3 percent from 2015 revenues.
8. Domestic revenues decreased 5 percent to $247.8 million from last year.
9. The company’s international revenues rose to $25.1 million, reflecting a 15 percent increase compared to 2015 revenues. On a constant currency basis, 2016 international revenues increased 15 percent compared to 2015 revenues.
10. The year saw direct revenues of $160.8 million, a 16 percent increase from 2015 direct revenues.
11. RTI saw double-digit growth in its spine, surgical specialties, cardiothoracic and international businesses.
More articles on devices:
Ted Davis named President and CEO of Active Implants — 4 details
Award-winning iWalk2.0 offers alternative to crutches — 5 notes
Wenzel Spine announces acquisition of Interspinous & Facet Fixation product platforms
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
